Efficacy of single-hormone and dual-hormone artificial pancreas during continuous and interval exercise in adult patients with type 1 diabetes: randomised controlled crossover trial

Diabetologia

Volumn 59, Issue 12, 2016, Pages 2561-2571

  Taleb, Nadine ^a,b   Emami, Ali ^a,c   Suppere, Corinne ^a   Messier, Virginie ^a   Legault, Laurent ^d   Ladouceur, Martin ^e   Chiasson, Jean Louis ^e,f   Haidar, Ahmad ^g   Rabasa Lhoret, Rémi ^a,b,f  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d MONTREAL CHILDREN S HOSPITAL   (Canada)

^e CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^f Montreal Diabetes Research Center   (Canada)

^g MCGILL UNIVERSITY   (Canada)

Author keywords

Artificial pancreas; Exercise; Glucagon; Hypoglycaemia; Type 1 diabetes

Indexed keywords

GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; INSULIN ASPART; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; INSULIN;

ADULT; ARTICLE; ARTIFICIAL PANCREAS; BICYCLE ERGOMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETIC PATIENT; ENERGY EXPENDITURE; EXERCISE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; INTERVENTION STUDY; MONOTHERAPY; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ALGORITHM; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; FEMALE; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADULT; ALGORITHMS; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; EXERCISE; FEMALE; GLUCAGON; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PANCREAS, ARTIFICIAL; YOUNG ADULT;

EID: 84990869185     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-016-4107-0     Document Type: Article

References (34)

1. Armstrong MJ, Sigal RJ (2013) Physical activity clinical practice guidelines: what’s new in 2013? Can J Diabetes 37:363–6
2. Chimen M, Kennedy A, Nirantharakumar K, Pang TT, Andrews R, Narendran P (2012) What are the health benefits of physical activity in type 1 diabetes mellitus? A literature review. Diabetologia 55:542–51
3. Tielemans SM, Soedamah-Muthu SS, de Neve M et al (2013) Association of physical activity with all-cause mortality and incident and prevalent cardiovascular disease among patients with type 1 diabetes: The EURODIAB Prospective Complications Study. Diabetologia 56:82–91
4. Plotnikoff RC, Taylor LM, Wilson PM et al (2006) Factors associated with physical activity in Canadian adults with diabetes. Med Sci Sports Exerc 38:1526–34
5. Brazeau A-S, Rabasa-Lhoret R, Irene S, Mircescu H (2008) Barriers to physical activity among patients with type 1 diabetes. Diabetes Care 31:2108–9
6. McMahon SK, Ferreira LD, Ratnam N et al (2007) Glucose requirements to maintain euglycemia after moderate-intensity afternoon exercise in adolescents with type 1 diabetes are increased in a biphasic manner. J Clin Endocrinol Metab 92:963–8
7. Tansey MJ, Tsalikian E, Beck RW et al (2006) The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes. Diabetes Care 29:20–5
8. Tsalikian E, Kollman C, Tamborlane WB et al (2006) Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin. Diabetes Care 29:2200–4
9. Rabasa-Lhoret R, Bourque J, Ducros F, Chiasson JL (2001) Guidelines for premeal insulin dose reduction for postprandial exercise of different intensities and durations in type 1 diabetic subjects treated intensively with a basal-bolus insulin regimen (ultralente-lispro). Diabetes Care 24:625–30
10. Riddell MC, Bar-Or O, Ayub BV, Calvert RE, Heigenhauser GJ (1999) Glucose ingestion matched with total carbohydrate utilization attenuates hypoglycemia during exercise in adolescents with IDDM. Int J Sport Nutr 9:24–34
11. Campbell MD, Walker M, Bracken RM et al (2015) Insulin therapy and dietary adjustments to normalize glycemia and prevent nocturnal hypoglycemia after evening exercise in type 1 diabetes: a randomized controlled trial. BMJ Open Diabetes Res Care 3:e000085
12. Chu L, Hamilton J, Riddell MC (2011) Clinical management of the physically active patient with type 1 diabetes. Phys Sportsmed 39:64–77
13. Hovorka R (2011) Closed-loop insulin delivery: from bench to clinical practice. Nat Rev Endocrinol 7:385–95
14. El-Khatib FH, Russell SJ, Magyar KL et al (2014) Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes. J Clin Endocrinol Metab 99:1701–11
15. Thabit H, Tauschmann M, Allen JM et al (2015) Home use of an artificial beta cell in type 1 diabetes. N Engl J Med 273:2129–40
16. Haidar A, Legault L, Dallaire M et al (2013) Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial. CMAJ 185:297–305
17. Castle JR, Engle JM, El Youssef J et al (2010) Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 diabetes. Diabetes Care 33:1282–7
18. Haidar A, Legault L, Messier V, Mitre TM, Leroux C, Rabasa-Lhoret R (2015) Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial. Lancet Diabetes Endocrinol 3:17–26
19. Haidar A, Legault L, Matteau-Pelletier L et al (2015) Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial. Lancet Diabetes Endocrinol 3:595–604
20. Haidar A, Rabasa-lhoret R, Legault L et al (2016) Single-and dual-hormone artificial pancreas for overnight glucose control in type 1 diabetes. J Clin Endocrinol Metab 101:214–23
21. Elleri D, Allen JM, Kavita Kumareswaran K et al (2013) Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes randomized clinical trial. Diabetes Care 36:838–44
22. Jacobs PG, Resalat N, El Youssef J et al (2015) Incorporating an exercise detection, grading, and hormone dosing algorithm into the artificial pancreas using accelerometry and heart rate. J Diabetes Sci Technol 5:1175–84
23. Storer TW, Davis JA, Caiozzo VJ (1990) Accurate prediction of VO2max in cycle ergometry. Med Sci Sports Exerc 22:704–12
24. Maahs DM, DeSalvo D, Pyle L et al (2015) Effect of acetaminophen on CGM glucose in an outpatient setting. Diabetes Care 38:e158–e159
25. Tonoli C, Heyman E, Roelands B et al (2012) Effects of different types of acute and chronic (training) exercise on glycaemic control in type 1 diabetes mellitus: a meta-analysis. Sports Med 42:1059–80
26. Luijf YM, Devries JH, Zwinderman K et al (2013) Day and night closed-loop control in adults with type 1 diabetes. Diabetes Care 36:3882–7
27. Taleb N, Emami A, Suppere C et al (2016) Comparison of two continuous glucose monitoring systems, Dexcom G4 Platinum and Medtronic Paradigm Veo Enlite, at rest and during exercise. Diabetes Technol Ther 18:561–567
28. Henriksson J (1995) Influence of exercise on insulin sensitivity. J Cardiovasc Risk 2:303–9
29. Yardley JE, Sigal RJ (2015) Exercise strategies for hypoglycemia prevention in individuals with type 1 diabetes. Diabetes Spectr 28:32–8
30. Hinshaw L, Mallad A, Dalla Man C et al (2015) Glucagon sensitivity and clearance in type 1 diabetes: insights from in vivo and in silico experiments. Am J Physiol Endocrinol Metab 309:E474–E486
31. Redmon JB, Kubo SH, Robertson RP (1995) Glucose, insulin, and glucagon levels during exercise in pancreas transplant recipients. Diabetes Care 18:457–62
32. Guelfi KJ, Jones TW, Fournier PA (2005) The decline in blood glucose levels is less with intermittent high-intensity compared with moderate exercise in individuals with type 1 diabetes. Diabetes Care 28:1289–94
33. Yardley J, Mollard R, MacIntosh A et al (2013) Vigorous intensity exercise for glycemic control in patients with type 1 diabetes. Can J Diabetes 37:427–32
34. Guelfi KJ, Ratnam N, Smythe GA, Jones TW, Fournier PA (2007) Effect of intermittent high-intensity compared with continuous moderate exercise on glucose production and utilization in individuals with type 1 diabetes. Am J Physiol Endocrinol Metab 292:E865–E870